Septerna (SEPN) Other Operating Expenses (2023 - 2026)
Septerna (SEPN) recorded quarterly Other Operating Expenses of -$33.7 million in Q1 2026, down 369.34% quarter-over-quarter from $12.5 million in Q3 2025, and down 58.67% on a YoY basis from -$81.5 million in Q1 2025.
Septerna (SEPN) Other Operating Expenses (2023 - 2026) Analysis & Trends
Septerna's Other Operating Expenses history runs 3 years deep, the most recent figure standing at -$33.7 million for Q1 2026.
- In Q1 2026, Other Operating Expenses fell 58.67% year-over-year to -$33.7 million; the TTM figure through Mar 2026 stood at -$21.2 million (changed 0.24% YoY), while the FY2025 annual figure was $12.5 million, changed N/A from the prior year.
- Other Operating Expenses was -$33.7 million for Q1 2026 at Septerna, down from $12.5 million in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $12.5 million in Q3 2025 to a low of -$47.6 million in Q4 2023.
- Historically, Other Operating Expenses has averaged -$22.5 million across 3 years, with a median of -$27.4 million in 2025.
- Biggest YoY gain for Other Operating Expenses was 58.67% in 2026; the steepest drop was 58.67% in 2026.
- A 3-year view of Other Operating Expenses shows it stood at -$47.6 million in 2023, then soared by 126.25% to $12.5 million in 2025, then slumped by 369.34% to -$33.7 million in 2026.
- The last three Other Operating Expenses figures came in at -$33.7 million (Q1 2026), $12.5 million (Q3 2025), and -$21.2 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Septerna | 1.60 Bn | 1.60 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -33.67 Mn |
| Sep 30, 2025 | 12.50 Mn |
| Mar 31, 2025 | -21.22 Mn |
| Dec 31, 2023 | -47.63 Mn |